Compositions and methods concerning immune tolerance
US12383617B2 · kind B2 · utility
0Cited by
140References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 9, 2019 |
| Grant date | Aug 12, 2025 |
| Priority date | — |
| Expiry date | Dec 15, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2239/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides compositions comprising mannose-fused antigens to target mannose receptors. The compositions may be used to prevent immunity or reduce an immune response protein-based drugs that would otherwise elicit an immune response.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.